GPR56/ADGRG1 Is a Platelet Collagen-Responsive GPCR and Hemostatic Sensor of Shear Force

Total Page:16

File Type:pdf, Size:1020Kb

GPR56/ADGRG1 Is a Platelet Collagen-Responsive GPCR and Hemostatic Sensor of Shear Force GPR56/ADGRG1 is a platelet collagen-responsive GPCR and hemostatic sensor of shear force Jennifer Yeunga, Reheman Adilia, Emily N. Stringhama, Rong Luob, Alexander Vizurragaa, Luciana K. Rosselli-Muraia, Hannah M. Stovekena, Maiya Yua, Xianhua Piaob,c, Michael Holinstata,d, and Gregory G. Talla,1 aDepartment of Pharmacology, University of Michigan Medical Center, Ann Arbor, MI 48109; bDepartment of Medicine, Boston Children’s Hospital and Harvard Medical School, Boston, MA 02115; cNewborn Brain Research Institute, Department of Pediatrics, Weill Institute for Neuroscience, University of California, San Francisco, CA 94158; and dDepartment of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109 Edited by Robert J. Lefkowitz, Howard Hughes Medical Institute, Durham, NC, and approved September 14, 2020 (received for review May 6, 2020) Circulating platelets roll along exposed collagen at vessel injury The differences in the experimental approaches used to inves- sites and respond with filipodia protrusion, shape change, and tigate platelet responses to collagen have offered varied inter- surface area expansion to facilitate platelet adhesion and plug pretations of whether GPVI is the key signaling receptor that acts formation. Various glycoproteins were considered to be both to initiate platelet activation (2, 7, 8, 13). For example, exogenous collagen responders and mediators of platelet adhesion, yet the collagen promotes sustained GPVI/Fc Receptor gamma (FcRγ) signaling kinetics emanating from these receptors do not fully signaling through phospholipase Cγ2(PLCγ2), but the Ca+2 mo- account for the rapid platelet cytoskeletal changes that occur in bilization output and kinetics of this multistep signaling pathway blood flow. We found the free N-terminal fragment of the adhe- may not fully account for the quick-onset cytoskeletal changes that sion G protein-coupled receptor (GPCR) GPR56 in human plasma are required for platelet deceleration in rapid blood flow (1, 17). and report that GPR56 is the platelet receptor that transduces sig- Thus, the putative existence of other rapid-acting platelet collagen nals from collagen and blood flow-induced shear force to activate receptors has been considered. These receptor(s) may be en- − − G protein 13 signaling for platelet shape change. Gpr56 / mice gaged prior to or concomitantly with the glycoprotein collagen have prolonged bleeding, defective platelet plug formation, and receptors (7). delayed thrombotic occlusion. Human and mouse blood perfusion Heterotrimeric G protein 13 (G13) signaling is required to MEDICAL SCIENCES studies demonstrated GPR56 and shear-force dependence of plate- stimulate the cytoskeletal-dependent platelet shape changes in let adhesion to immobilized collagen. Our work places GPR56 as an response to collagen (18). Gα13-GTP (guanosine triphosphate) initial collagen responder and shear-force transducer that is essen- rapidly and robustly activates Rho family small G protein sig- tial for platelet shape change during hemostasis. naling to induce actin polymerization (19). Accounting for the means of G13 activation is not readily explained by the actions of hemostasis | platelets | adhesion GPCR | collagen | signal transduction the current repertoire of platelet collagen receptors. Here, we identified the collagen-responsive, G13-coupled, G protein-coupled emostasis is the physiological wound healing process that receptor (GPCR) GPR56 or ADGRG1 on the surface of plate- Hprevents blood loss while maintaining normal blood flow. lets (20–23). GPR56 is an adhesion G protein-coupled receptor Platelets are anucleate cell fragments that serve as major con- tributors to hemostatic plug formation. The process is initiated Significance by platelet surface receptor engagement with subendothelial collagen of the extracellular matrix that becomes exposed during We identified the known collagen receptor GPR56/ADGRG1 on vessel wall injury (1–3). The initiating hemostatic step involves platelets. GPR56 is an adhesion G protein-coupled receptor that platelet glycoprotein Ibα (GPIbα) transiently tethering to collagen- becomes activated following forced dissociation of its N-terminal bound von Willebrand factor (vWF) (2–5). A multistep mechanism fragment and C-terminal fragment or seven-transmembrane ensues in which multiple receptors including glycoprotein VI spanning domain (7TM). Fragment dissociation reveals the (GPVI) and integrin α2β1 participate in platelet spreading, activa- cryptic stalk of the 7TM, which acts as a tethered peptide ago- tion, stable adhesion, and the aggregation events that are necessary nist, and for GPR56, this activates platelet G13 signaling. GPR56 to support thrombus growth (6–8). Within the sequential activating pharmacological probes activated platelets to undergo shape events, tethered platelets undergo rapid reorganization of the cy- change and aggregation, which are critical for the formation of −/− toskeletal structure, expanding from discoid to spherical shapes in hemostatic plugs. Gpr56 mice exhibit prolonged bleeding, order to spread over the damaged surface (9). Actin polymerization defective platelet plug formation in vessel injury assays, and within platelets permits the development and extension of filopodia delayed thrombotic vessel occlusion. Shear-force dependency of protrusions and lamellipodia that enable platelet deceleration in platelet adhesion to immobilizedcollagenwasfoundtobe the blood flow, flattening and stable adhesion. Activated platelets GPR56 dependent. release storage granule contents, including autocrine and paracrine platelet agonists that fulfill the platelet activation process (2, 10, Author contributions: J.Y., A.V., L.K.R.-M., H.M.S., and G.G.T. designed research; J.Y., R.A., E.N.S., A.V., L.K.R.-M., H.M.S., M.Y., and G.G.T. performed research; J.Y., R.L., X.P., and 11). These events are prerequisite to secondary platelet recruitment G.G.T. contributed new reagents/analytic tools; J.Y., E.N.S., A.V., L.K.R.-M., H.M.S., M.H., and formation of stable clots. and G.G.T. analyzed data; and J.Y. and G.G.T. wrote the paper. Dynamic glycoprotein receptor interactions with collagen have The authors declare no competing interest. been viewed as the dominant initiating events leading to platelet This article is a PNAS Direct Submission. plug formation. Arteriole injury and platelet activation experi- This open access article is distributed under Creative Commons Attribution-NonCommercial- ments using a GPVI-deficient mouse model showed defects in NoDerivatives License 4.0 (CC BY-NC-ND). hemostatic plug formation and platelet adhesion to collagen (12, 1To whom correspondence may be addressed. Email: [email protected]. 13). However, additional measures demonstrated that GPVI- This article contains supporting information online at https://www.pnas.org/lookup/suppl/ deficient mice have negligibly prolonged bleeding times and no doi:10.1073/pnas.2008921117/-/DCSupplemental. impairment in induced occlusive thrombus formation (14–16). First published October 23, 2020. www.pnas.org/cgi/doi/10.1073/pnas.2008921117 PNAS | November 10, 2020 | vol. 117 | no. 45 | 28275–28286 Downloaded by guest on October 1, 2021 (AGPCR), a receptor subclass distinguished by the presence of a markers were measured by flow cytometry. Human platelets, but GPCR autoproteolysis-inducing domain that self-cleaves the re- not the RBCs, stained positive for GPR56 and CD41, whereas ceptors at a precise extracellular site proximal to the start of the RBCs stained positive for CD235 but not GPR56 (Fig. 2A). There first transmembrane span (TM1) of the seven-transmembrane was variability of GPR56 abundance among platelets isolated from bundle (24). Self-cleavage is constitutive, and the two resulting the different human donors (SI Appendix,Fig.S2A). Intact plate- receptor pieces, termed the N-terminal fragment (NTF) and lets were costained with the GPR56 NTF antibody and fluorescein C-terminal fragment (CTF), remain noncovalently bound. Recent isothiocyanate (FITC)-phalloidin and visualized by fluorescent biochemical evidence demonstrated that dissociation of the two microscopy. Inclusion of the GPR56 rNTF during the antibody receptor fragments resulted in strong activation of G protein sig- incubation blocked the punctate cell surface GPR56 NTF anti- naling (22, 23). Dissociation of the NTF unveils a stalk peptide body signal (Fig. 2B). Cytosol-free membrane homogenates were emanating from TM1 that acts as a tethered peptide agonist to prepared from human platelets obtained from five donors. The activate the CTF (23, 25). One proposed physiological mechanism membranes were quantitatively immunoblotted with an antibody to of AGPCR activation is through shear force-mediated NTF/CTF detect the GPR56 CTF (Fig. 2C). GPR56 was present in each dissociation. The NTF becomes immobilized to its protein ligand, platelet membrane preparation, and variable abundance was ob- and the force created by cell movement drives the dissociation served, coinciding with the flow cytometry results. The platelet event. Our work shows that GPR56 is a platelet collagen GPCR membrane preparations were then treated with urea to dissociate that has the critical role of providing early-onset G13 activation to the GPR56 CTF and NTF. The majority of platelet GPR56 was facilitate the platelet shape changes and integrin activation that deemed to be self-cleaved as the transmembrane intercalated are necessary for efficient hemostasis
Recommended publications
  • Edinburgh Research Explorer
    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
    [Show full text]
  • CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma
    International Journal of Molecular Sciences Article CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma 1, 2,3,4, 5 6 7 Ju-Fang Liu y, Chiang-Wen Lee y, Chih-Yang Lin , Chia-Chia Chao , Tsung-Ming Chang , Chien-Kuo Han 8, Yuan-Li Huang 8, Yi-Chin Fong 9,10,* and Chih-Hsin Tang 8,11,12,* 1 School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei City 11031, Taiwan; [email protected] 2 Department of Orthopaedic Surgery, Chang Gung Memorial Hospital, Puzi City, Chiayi County 61363, Taiwan; [email protected] 3 Department of Nursing, Division of Basic Medical Sciences, and Chronic Diseases and Health Promotion Research Center, Chang Gung University of Science and Technology, Puzi City, Chiayi County 61363, Taiwan 4 Research Center for Industry of Human Ecology and Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Guishan Dist., Taoyuan City 33303, Taiwan 5 School of Medicine, China Medical University, Taichung 40402, Taiwan; [email protected] 6 Department of Respiratory Therapy, Fu Jen Catholic University, New Taipei City 24205, Taiwan; [email protected] 7 School of Medicine, Institute of Physiology, National Yang-Ming University, Taipei City 11221, Taiwan; [email protected] 8 Department of Biotechnology, College of Health Science, Asia University, Taichung 40402, Taiwan; [email protected] (C.-K.H.); [email protected] (Y.-L.H.) 9 Department of Sports Medicine, College of Health Care, China Medical University, Taichung 40402, Taiwan 10 Department of Orthopedic Surgery, China Medical University Beigang Hospital, Yunlin 65152, Taiwan 11 Department of Pharmacology, School of Medicine, China Medical University, Taichung 40402, Taiwan 12 Chinese Medicine Research Center, China Medical University, Taichung 40402, Taiwan * Correspondence: [email protected] (Y.-C.F.); [email protected] (C.-H.T.); Tel.: +886-4-2205-2121-7726 (C.-H.T.); Fax: +886-4-2233-3641 (C.-H.T.) These authors contributed equally to this work.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • G-Protein-Coupled Receptor Signaling and Polarized Actin Dynamics Drive
    RESEARCH ARTICLE elifesciences.org G-protein-coupled receptor signaling and polarized actin dynamics drive cell-in-cell invasion Vladimir Purvanov, Manuel Holst, Jameel Khan, Christian Baarlink, Robert Grosse* Institute of Pharmacology, University of Marburg, Marburg, Germany Abstract Homotypic or entotic cell-in-cell invasion is an integrin-independent process observed in carcinoma cells exposed during conditions of low adhesion such as in exudates of malignant disease. Although active cell-in-cell invasion depends on RhoA and actin, the precise mechanism as well as the underlying actin structures and assembly factors driving the process are unknown. Furthermore, whether specific cell surface receptors trigger entotic invasion in a signal-dependent fashion has not been investigated. In this study, we identify the G-protein-coupled LPA receptor 2 (LPAR2) as a signal transducer specifically required for the actively invading cell during entosis. We find that 12/13G and PDZ-RhoGEF are required for entotic invasion, which is driven by blebbing and a uropod-like actin structure at the rear of the invading cell. Finally, we provide evidence for an involvement of the RhoA-regulated formin Dia1 for entosis downstream of LPAR2. Thus, we delineate a signaling process that regulates actin dynamics during cell-in-cell invasion. DOI: 10.7554/eLife.02786.001 Introduction Entosis has been described as a specialized form of homotypic cell-in-cell invasion in which one cell actively crawls into another (Overholtzer et al., 2007). Frequently, this occurs between tumor cells such as breast, cervical, or colon carcinoma cells and can be triggered by matrix detachment (Overholtzer et al., 2007), suggesting that loss of integrin-mediated adhesion may promote cell-in-cell invasion.
    [Show full text]
  • G-Protein-Coupled Receptor Heteromer Dynamics
    Commentary 4215 G-protein-coupled receptor heteromer dynamics Jean-Pierre Vilardaga1,2,*, Luigi F. Agnati3, Kjell Fuxe4 and Francisco Ciruela5 1Laboratory for GPCR Biology, Department of Pharmacology and Chemical Biology, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15261, USA 2Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA 3IRCCS, San Camillo, Lido Venezia, Italy 4Department of Neuroscience, Karolinska Institute, Stockholm SE-17177, Sweden 5Pharmacology Unit, Department of Pathology and Experimental Therapy, Faculty of Medicine, University of Barcelona, 08907 Barcelona, Spain *Author for correspondence ([email protected]) Journal of Cell Science 123, 000-000 © 2010. Published by The Company of Biologists Ltd doi:10.1242/jcs.063354 Summary G-protein-coupled receptors (GPCRs) represent the largest family of cell surface receptors, and have evolved to detect and transmit a large palette of extracellular chemical and sensory signals into cells. Activated receptors catalyze the activation of heterotrimeric G proteins, which modulate the propagation of second messenger molecules and the activity of ion channels. Classically thought to signal as monomers, different GPCRs often pair up with each other as homo- and heterodimers, which have been shown to modulate signaling to G proteins. Here, we discuss recent advances in GPCR heteromer systems involving the kinetics of the early steps in GPCR signal transduction, the dynamic property of receptor–receptor interactions, and how the formation of receptor heteromers modulate the kinetics of G-protein signaling. Key words: G-protein-coupled receptors, Heterodimers, Signaling Introduction the signaling and trafficking mechanisms of GPCRs is thus central G-protein-coupled receptors (GPCRs) constitute the main family for the development of new and safer therapies for many of cell surface receptors for a large variety of chemical stimuli physiological and psychological disorders.
    [Show full text]
  • G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes
    Int. J. Mol. Sci. 2014, 15, 1112-1142; doi:10.3390/ijms15011112 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes Benoît T. Roux 1 and Graeme S. Cottrell 2,* 1 Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK; E-Mail: [email protected] 2 Reading School of Pharmacy, University of Reading, Reading RG6 6UB, UK * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +44-118-378-7027; Fax: +44-118-378-4703. Received: 4 December 2013; in revised form: 20 December 2013 / Accepted: 8 January 2014 / Published: 16 January 2014 Abstract: G protein-coupled receptors (GPCRs) are important cell signaling mediators, involved in essential physiological processes. GPCRs respond to a wide variety of ligands from light to large macromolecules, including hormones and small peptides. Unfortunately, mutations and dysregulation of GPCRs that induce a loss of function or alter expression can lead to disorders that are sometimes lethal. Therefore, the expression, trafficking, signaling and desensitization of GPCRs must be tightly regulated by different cellular systems to prevent disease. Although there is substantial knowledge regarding the mechanisms that regulate the desensitization and down-regulation of GPCRs, less is known about the mechanisms that regulate the trafficking and cell-surface expression of newly synthesized GPCRs. More recently, there is accumulating evidence that suggests certain GPCRs are able to interact with specific proteins that can completely change their fate and function. These interactions add on another level of regulation and flexibility between different tissue/cell-types.
    [Show full text]
  • Interleukin-21 in Immunity and Autoimmunity
    Interleukin-21 in immunity and autoimmunity Alexis Vogelzang A thesis submitted for the degree of Doctor of Philosophy in the Faculty of Medicine, University of New South Wales Mucosal Autoimmunity Unit, Garvan Institute of Medical Research Sydney, Australia Awarded September 2010 1 ORIGINALITY STATEMENT ‘I hereby declare that this submission is my own work and to the best of my knowledge it contains no materials previously published or written by another person, or substantial proportions of material which have been accepted for the award of any other degree or diploma at UNSW or any other educational institution, except where due acknowledgement is made in the thesis. Any contribution made to the research by others, with whom I have worked at UNSW or elsewhere, is explicitly acknowledged in the thesis. I also declare that the intellectual content of this thesis is the product of my own work, except to the extent that assistance from others in the project's design and conception or in style, presentation and linguistic expression is acknowledged.’ Signed …………………………………………….............. Alexis Vogelzang Date …………………………………………….............. 2 COPYRIGHT STATEMENT ‘I hereby grant the University of New South Wales or its agents the right to archive and to make available my thesis or dissertation in whole or part in the University libraries in all forms of media, now or here after known, subject to the provisions of the Copyright Act 1968. I retain all proprietary rights, such as patent rights. I also retain the right to use in future works (such as articles or books) all or part of this thesis or dissertation.
    [Show full text]
  • Synaptamide Activates the Adhesion GPCR GPR110 (ADGRF1) Through GAIN Domain Binding
    ARTICLE https://doi.org/10.1038/s42003-020-0831-6 OPEN Synaptamide activates the adhesion GPCR GPR110 (ADGRF1) through GAIN domain binding Bill X. Huang1, Xin Hu2, Heung-Sun Kwon1, Cheng Fu1, Ji-Won Lee1, Noel Southall2, Juan Marugan2 & ✉ Hee-Yong Kim1 1234567890():,; Adhesion G protein-coupled receptors (aGPCR) are characterized by a large extracellular region containing a conserved GPCR-autoproteolysis-inducing (GAIN) domain. Despite their relevance to several disease conditions, we do not understand the molecular mechanism by which aGPCRs are physiologically activated. GPR110 (ADGRF1) was recently deorphanized as the functional receptor of N-docosahexaenoylethanolamine (synaptamide), a potent synap- togenic metabolite of docosahexaenoic acid. Thus far, synaptamide is the first and only small- molecule endogenous ligand of an aGPCR. Here, we demonstrate the molecular basis of synaptamide-induced activation of GPR110 in living cells. Using in-cell chemical cross-linking/ mass spectrometry, computational modeling and mutagenesis-assisted functional assays, we discover that synaptamide specifically binds to the interface of GPR110 GAIN subdomains through interactions with residues Q511, N512 and Y513, causing an intracellular conforma- tional change near TM6 that triggers downstream signaling. This ligand-induced GAIN-tar- geted activation mechanism provides a framework for understanding the physiological function of aGPCRs and therapeutic targeting in the GAIN domain. 1 Laboratory of Molecular Signaling, National Institute on Alcohol Abuse
    [Show full text]
  • Direct Coupling of Detergent Purified Human Mglu5 Receptor To
    www.nature.com/scientificreports OPEN Direct coupling of detergent purifed human mGlu5 receptor to the heterotrimeric G proteins Gq Received: 24 July 2017 Accepted: 26 February 2018 and Gs Published: xx xx xxxx Chady Nasrallah1, Karine Rottier1, Romain Marcellin1, Vincent Compan1, Joan Font2, Amadeu Llebaria 2, Jean-Philippe Pin 1, Jean-Louis Banères3 & Guillaume Lebon1 The metabotropic glutamate (mGlu) receptors are class C G protein-coupled receptors (GPCRs) that modulate synaptic activity and plasticity throughout the mammalian brain. Signal transduction is initiated by glutamate binding to the venus fytrap domains (VFT), which initiates a conformational change that is transmitted to the conserved heptahelical domains (7TM) and results ultimately in the activation of intracellular G proteins. While both mGlu1 and mGlu5 activate Gαq G-proteins, they also increase intracellular cAMP concentration through an unknown mechanism. To study directly the G protein coupling properties of the human mGlu5 receptor homodimer, we purifed the full-length receptor, which required careful optimisation of the expression, N-glycosylation and purifcation. We successfully purifed functional mGlu5 that activated the heterotrimeric G protein Gq. The high- afnity agonist-PAM VU0424465 also activated the purifed receptor in the absence of an orthosteric agonist. In addition, it was found that purifed mGlu5 was capable of activating the G protein Gs either upon stimulation with VU0424465 or glutamate, although the later induced a much weaker response. Our fndings provide important mechanistic insights into mGlu5 G protein-dependent activity and selectivity. Te metabotropic glutamate (mGlu) receptors belong to class C of the large family of G protein-coupled receptors (GPCRs). mGlu receptors are localized to both synaptic and extra-synaptic sites in neurons and glia where they modulate the strength of synaptic transmission by sensing the extracellular concentration of glutamate.
    [Show full text]
  • Phytosphingosine-1-Phosphate Stimulates Chemotactic Migration of L2071 Mouse Fibroblasts Via Pertussis Toxin-Sensitive G-Proteins
    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 39, No. 2, 185-194, April 2007 Phytosphingosine-1-phosphate stimulates chemotactic migration of L2071 mouse fibroblasts via pertussis toxin-sensitive G-proteins 1,2 1 Mi-Kyoung Kim , Kyoung Sun Park , demonstrates that PhS1P stimulates at least two 3 3 Hyuck Lee , Young Dae Kim , different signaling cascades, one is a PTX-insensi- 1,2 1,2,4 Jeanho Yun and Yoe-Sik Bae tive but phospholipase C dependent intracellular calcium increase, and the other is a PTX-sensitive 1 Medical Research Center for Cancer Molecular Therapy chemotactic migration mediated by phosphoino - 2 Department of Biochemistry sitide 3-kinase and p38 kinase. 3 Department of Internal Medicine Keywords: calcium signaling; chemotaxis; fibroblasts; College of Medicine, Dong-A University GTP-binding proteins; pertussis toxin; phytosphingo- Busan 602-714, Korea 4 sine-1-phosphate Corresponding author: Tel, 82-51-240-2889; Fax, 82-51-241-6940; E-mail, [email protected] Introduction Accepted 9 February 2007 Many reports have demonstrated the involvement of Abbreviations: BAPTA/AM, 1,2-bis (Aminophenoxy) ethane-N,N,N’,N’- 2+ lipid factors in cellular responses. In particular, tetraacetoxymethyl ester; [Ca ]i, intracellular calcium concentration; sphingosine-1-phosphate (S1P) and lysophosphati- GPCRs, G-protein coupled receptors; IP3, inositol-1,4,5-trisphos- dic acid (LPA) are important lipid mediators, which phate; LPA, lysophosphatidic acid; PD98059, 2’-amino-3’-meth- modulate a wide range of physiological activities oxyflavone; PhS1P, phytosphingosine-1-phosphate; PI3K, phosphati- (van Corven et al., 1989; English et al., 1999; Wang dylinositol-3-kinase; PTX, pertussis toxin; LY294002, 2-(4-Mor- et al., 1999; Fishman et al., 2001; Cummings et al., pholinyl)-8-phenyl-4H-1-benzopyran-4-one; S1P, sphingosine-1- 2002; Idzko et al., 2002; Kim et al., 2004).
    [Show full text]
  • Identi Cation of Signi Cant Genes with Invasive Promotion in Non-Functional Pituitary Adenoma Via Bioinformatical Analysis
    Identication of signicant genes with invasive promotion in non-functional pituitary adenoma via bioinformatical analysis An Shuo Wang Anhui Provincial Hospital Hao Xu Anhui Provincial Hospital Ming Hui Zeng Anhui Provincial Hospital Fei Wang ( [email protected] ) Anhui Provincial Hospital https://orcid.org/0000-0003-4877-4542 Research Keywords: Invasive non-functional pituitary adenoma, Bioinformational analysis, PEGG pathway, Differentially expressed genes, GEO2R Posted Date: January 19th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-146994/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/19 Abstract Background Non-functional pituitary adenoma (NFPA) is a disease with a high incidence, which accounts for a large part of pituitary tumors and plays a pivotal role. While invasive NFPAs which have not any endocrinology manifestations and space-occupying symptoms at early stages account for about 30 percent of NFPAs. The purpose of the present academic work was to identify signicant genes with invasive promotion and their underlying mechanisms. Methods Gene expression proles of GSE51618 was available from GEO database. There are 4 non-invasive NFPA tissues, 3 invasive NFPA tissues and 3 normal tissues in the prole datasets. Differentially expressed genes (DEGs) between non-invasive NFPA tissues and invasive NFPA tissues were picked out by GEO2R online tool. There were total of 226 up-regulated genes and 298 down-regulated genes. Next, we made use of the Database for Annotation, Visualization and Integrated Discovery (DAVID) to analyze Kyoto Encyclopedia of Gene and Genome (KEGG) pathway, gene ontology (GO) and Kaplan Meier Plotter.
    [Show full text]
  • GPCR Expression Profiles Were Determined Using
    Supplemental Figures and Tables for Tischner et al., 2017 Supplemental Figure 1: GPCR expression profiles were determined using the NanoString nCounter System in 250 ng of pooled cell RNA obtained from freshly isolated CD4 T cells from naïve lymph nodes (CD4ln), spinal cord infiltrating CD4 T cells at peak EAE disease (CD4sc), and primary lung endothelial cells (luEC). Supplemental Figure 2: Array design and quality controls. A, Sorted leukocytes or endothelial cells were subjected to single‐cell expression analysis and re‐evaluated based on the expression of various identity‐defining genes. B, Expression of identity‐defining and quality control genes after deletion of contaminating or reference gene‐negative cells. Expression data are calculated as 2(Limit of detection(LoD) Ct – sample Ct) ; LoD Ct was set to 24. Supplemental Figure 3: Overview over GPCR expression frequencies in different freshly isolated immune cell populations and spinal cord endothelial cells as determined by single cell RT‐PCR. Abbreviations: CD4ln‐Tcon/CD4ln‐Treg, conventional (con) and regulatory (reg) CD4 T cells from lymph nodes (CD4ln) of naïve mice; CD4dr/CD4sc, CD4 T cells from draining lymph nodes (dr) or spinal cord (sc) at peak EAE disease; CD4spn2D/ CD4spn2DTh1/ CD4spn2DTh17, splenic CD4 T cells from 2D2 T cell receptor transgenic mice before (2D) and after in vitro differentiation towards Th1 (2DTh1) or Th17 (2DTh17); MonoSpn, splenic monocytes; CD11b_sc, spinal cord infiltrating CD11b‐ positive cells; sc_microglia, Ccr2neg,Cx3cr1pos microglia from spinal cord at peak disease; sc_macrophages, CCr2pos;Cx3cr1lo/neg macrophages from spinal cord at peak disease; BMDM_M1/BMDM_M2, bone marrow‐derived macrophages differentiated towards M1 or M2; ECscN and ECscEAE, spinal cord endothelial cells from naïve mice (N) and at peak EAE disease (EAE); SMC, smooth muscle cells from various vessel types (included as positive control to ascertain primer functionality).
    [Show full text]